2734168-69-3
Chemical Structure
HPK1-IN-10
- CAS No.: 2734168-69-3
- Formula:C31H34N6O2
- Molecular Weight:522.64
IUPAC Name: (3-(dimethylamino)azetidin-1-yl)(4-(5-(3-methyl-1,2,3,4,4a,5-hexahydrobenzo[b]pyrazino[1,2-d][1,4]oxazin-8-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl)methanone
InChIKey: OEHYREZCNWAJNA-UHFFFAOYSA-N
SMILES: O=C(N1CC(C1)N(C)C)C2=CC=C(C3=CNC4=NC=C(C5=CC(OCC6N7CCN(C6)C)=C7C=C5)C=C43)C=C2
Biological Activity: HPK1-IN-10 is potent inhibitor of HPK1. HPK1 is a serine/threonine protein kinase cloned from hematopoietic progenitor cells and belongs to the MAP4K family of mammalian Ste-20-related protein kinases. HPK1-IN-10 has the potential for the research of HPK1 related diseases (extracted from patent WO2021213317A1, compound 103) [1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
HPK1-IN-10 | HPK1-IN-10 is potent inhibitor of HPK1. HPK1 is a serine/threonine protein kinase cloned from hematopoietic progenitor cells and belongs to the MAP4K family of mammalian Ste-20-related protein kinases. HPK1-IN-10 has the potential for the research of HPK1 related diseases (extracted from patent WO2021213317A1, compound 103) . | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
